Lead compounds were tested in vitro against two mammalian cell lines to evaluate cytotoxicity. CRL-8155 human lymphocyte and HepG2 human hepatocyte cells (ATCC, Manassas, VA) were seeded in 96-well plates and incubated at 37°C for 48 h in the presence of test compound (serial-2 dilutions, in triplicate). At the end of the incubation period, cells were visually assessed before alamarBlueTM (Thermo Fisher, Waltham, MA), a resazurin-based cell viability reagent which measures metabolic activity, was added to the plates and fluorescence measured on a BioTek FLx-800 microplate reader (BioTek Instruments, Winooski, VT). Fluorescence signals resulting from cell viability changes were compared with control wells to calculate 50% cytotoxic concentrations (CC50) values.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.